News | News By Subject | News by Disease News By Date | Search News

Pain control News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA     12/30/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab     10/18/2016
Gilead (GILD) Might Avoid Fighting Celgene (CELG), But Allergan (AGN), Intercept Pharma (ICPT) and Novartis AG (NVS) Await     10/4/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab     9/20/2016
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters     9/6/2016
AcelRx (ACRX)' ARX-04 Phase 3 Trial Met its Primary Endpoint     8/15/2016
Endo International (ENDP) Withdraws Its Supplemental NDA for Pain Drug OPANA     8/12/2016
Recro Pharma (REPH) Shares Rocket as Intravenous Painkiller Succeeds in Phase III Trial     7/27/2016
What Purdue Pharma L.P. Knew About a Oxycontin Ring that Pushed More than 1 Million Pills     7/11/2016
Unclear Whether FDA Took Into Account KemPharm (KMPH)'s Amendment Data in Rejecting Apadaz Application     6/14/2016
Innocoll (INNL)'s Painkiller Passes Final Phase III Tests, Heads for 2017 Launch     5/25/2016
Sanofi (SNY) Recalls Some Batches of Combiflam in India     5/12/2016
KemPharm (KMPH) Crashes After the FDA Votes Against Abuse-Deterrent Labeling for Pain Med     5/6/2016
Regeneron (REGN)'s Pain Drug Fasinumab Meets Goals in Late Stage Study     5/2/2016

News from Around the Web
University of Pennsylvania Should Rethink Over-Hyped Press Releases     1/11/2017
Tech Devices To Treat Chronic Pain Could Curb Opioid Use, SPR Therapeutics Reveals     1/6/2017
New Compound May Treat Pain Without Opioid- Or Marijuana-Use Side Effects, Indiana University Study     11/15/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
Can A "Smart" Pain Management System Be Alternative To Opioids For Chronic Pain?     11/4/2016
Specialists Alarmed About Children Prescribed Opium-Derived Painkillers     10/31/2016
"Fake Pills" May Help Ease Back Pain, Beth Israel Deaconess Medical Center Study     10/21/2016
New Opioids Could Relieve Pain Without Dangerous Side Effects, UCSF Study     10/17/2016
Why Does My Pain Come And Go?     10/6/2016
An Opioid Spray Showered Billionaire John Kapoor In Riches. Now He's Feeling The Pain     10/5/2016
Artificial Knee Implant Provides New Treatment Options For Joint Pain     9/30/2016
For Pain Therapeutics (PTIE) CEO, 3 FDA Rejections Are Worth $23 Million     9/27/2016
UVLrx Therapy Lights Up Charlatans Dealing In Medical Devices, UVLrx Therapeutics Reveals     9/26/2016
Wet Weather And No Sun Really Does Make Chronic Pain Worse, University of Manchester Study     9/7/2016
This Drug Compound Could End America's Painkiller Epidemic, Stanford University Researchers Say     8/19/2016

Press Releases
Egalet Release: Drug Company Receives FDA Approval For ARYMO ER (Morphine Sulfate) C-II, An Extended-Release Morphine Product Formulated With Abuse-Deterrent Properties For Treatment Of Chronic Pain     1/10/2017
AcelRx (ACRX) Provides Guidance On 2017 Milestones For ARX-04, Now Known As DSUVIA In The United States, For The Treatment Of Moderate-To-Severe Acute Pain     1/9/2017
AcelRx (ACRX) Announces DSUVIA As Brand Name For ARX-04 In The United States     1/9/2017
Sorrento (SRNE) Subsidiary, Scilex, Announces Key Endpoints Met In The European Union Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido     1/9/2017
SiteOne Therapeutics Announces Research and Development Agreement With Amgen (AMGN) to Advance Portfolio of Highly Selective, Potent Inhibitors of NaV1.7 for Acute and Chronic Pain     1/6/2017
Trevena (TRVN) Completes Enrollment Of Phase III APOLLO Pivotal Efficacy Trials Of Oliceridine For Moderate-To-Severe Acute Pain     1/4/2017
Custopharm Acquires Two ANDA Pharmaceutical Products From Perrigo (PRGO)     1/4/2017
CES 2017: NeuroMetrix (NURO) Brings Life-Enhancing Technology To Those Suffering From Chronic Pain     1/3/2017
Ironwood (IRWD) And Allergan (AGN) Report Topline Phase IIb Data Supporting Further Investigation Of Linaclotide Colonic Release-2 (CR2) For Abdominal Pain In Non-Constipation Subtypes Of IBS     12/22/2016
IMPAX Labs (IPXL) Launches Generic Version Of Kadian (Morphine Sulfate) Extended Release Capsules, USP CII     12/22/2016
Lannett (LCI) Announces Supplemental Approval For Morphine Sulfate Oral Solution CII, 20 Mg/Ml     12/19/2016
Grunenthal Receives Breakthrough Therapy Designation From U.S. FDA For Neridronic Acid For The Treatment Of CRPS     12/16/2016
Centrexion Touts Success of Phase IIb Study for Knee Osteoarthritis Pain     12/13/2016
Centrexion Announces Highly Statistically Significant Topline Results From Phase 2b Study Of CNTX-4975 In Patients With Knee Osteoarthritis Pain     12/13/2016
Flexion (FLXN) Submits New Drug Application For Zilretta To Treat Knee Osteoarthritis Pain     12/13/2016

//-->